Latest Breaking News On - Susan chor - Page 1 : comparemela.com

BofA Securities has downgraded Vir Biotechnology Inc (NASDAQ: VIR) to Neutral from Buy with a price target of $14, 

Shao shenCharlie yangGeoff meachamGilead sciences incVir biotechnology incBofa securitiesSusan chorAlexandria hammond